505
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Intratumoral perfusion may affect microwave ablation area of hepatocellular carcinoma

, , , &
Article: 2268892 | Received 27 Jun 2023, Accepted 05 Oct 2023, Published online: 06 Nov 2023

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.2166.
  • Ruiter SJS, Heerink WJ, de Jong KP. Liver microwave ablation: a systematic review of various FDA-approved systems. Eur Radiol. 2019;29(8):4026–4035. doi: 10.1007/s00330-018-5842-z.
  • Swan RZ, Sindram D, Martinie JB, et al. Operative microwave ablation for hepatocellular carcinoma: complications, recurrence, and long-term outcomes. J Gastrointest Surg. 2013;17(4):719–729. doi: 10.1007/s11605-013-2164-y.
  • Shehata MAH, El-Kady N, Hasaballah M, et al. Hypervascular nodules and stiffer liver are associated with recurrence after microwave ablation in patients with hepatocellular carcinoma: a Double-Center analysis. South Asian J Cancer. 2020;9(3):153–157. doi: 10.1055/s-0041-1723102.
  • Sparchez Z, Mocan T, Radu P, et al. Prognostic factors after percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma. Impact of incomplete ablation on recurrence and overall survival rates. J Gastrointestin Liver Dis. 2018;27(4):399–407. doi: 10.15403/jgld.2014.1121.274.pro.
  • Klebe J, Happel C, Grünwald F, et al. Visualization of tissue alterations in thyroid nodules after microwave ablation: sonographic versus scintigraphic imaging. Nucl Med Commun. 2015;36(3):260–267. doi: 10.1097/MNM.0000000000000242.
  • Pillai K, Akhter J, Chua TC, et al. Heat sink effect on tumor ablation characteristics as observed in monopolar radiofrequency, bipolar radiofrequency, and microwave, using ex vivo calf liver model. Medicine (Baltimore). 2015;94(9):e580. doi: 10.1097/MD.0000000000000580.
  • Chen R, Lu F, Wu F, et al. An analytical solution for temperature distributions in hepatic radiofrequency ablation incorporating the heat-sink effect of large vessels. Phys Med Biol. 2018;63(23):235026. doi: 10.1088/1361-6560/aaeef9.
  • Hocquelet A, Balageas P, Frulio N, et al. Aggressive intrasegmental recurrence of periportal hepatocellular carcinoma after radiofrequency ablation: role of ablative technique and heat-Sink effect? Radiology. 2015;276(3):932–933. doi: 10.1148/radiol.2015150661.
  • Bhardwaj N, Dormer J, Ahmad F, et al. Microwave ablation of the liver: a description of lesion evolution over time and an investigation of the heat sink effect. Pathology. 2011;43(7):725–731. doi: 10.1097/PAT.0b013e32834c356c.
  • Ringe KI, Lutat C, Rieder C, et al. Experimental evaluation of the heat sink effect in hepatic microwave ablation. PLoS One. 2015;10(7):e0134301. doi: 10.1371/journal.pone.0134301.
  • Wiggermann P, Wohlgemuth WA, Heibl M, et al. Dynamic evaluation and quantification of microvascularization during degradable starch microspheres transarterial chemoembolisation (DSM-TACE) of HCC lesions using contrast enhanced ultrasound (CEUS): a feasibility study. Clin Hemorheol Microcirc. 2013;53(4):337–348. doi: 10.3233/CH-2012-1555.
  • Haimerl M, Brünn K, Poelsterl S, et al. Quantitative evaluation of real-time maximum liver capacity (LiMAx) and time intensity curve (TIC) analysis in CEUS-based microperfusion. Clin Hemorheol Microcirc. 2017;67(3-4):373–382. doi: 10.3233/CH-179217.
  • Schaible J, Stroszczynski C, Beyer LP, et al. Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization. Clin Hemorheol Microcirc. 2019;73(1):95–104. doi: 10.3233/CH-199221.
  • Knieling F, Waldner MJ, Goertz RS, et al. Early response to anti-tumoral treatment in hepatocellular carcinoma—can quantitative contrast-enhanced ultrasound predict outcome? Ultraschall Med. 2013;34(1):38–46. doi: 10.1055/s-0032-1330387.
  • Zocco MA, Garcovich M, Lupascu A, et al. Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound. J Hepatol. 2013;59(5):1014–1021. doi: 10.1016/j.jhep.2013.06.011.
  • Zhou F, Yu XL, Liang P, et al. Microwave ablation is effective against liver metastases from gastric adenocarcinoma. Int J Hyperthermia. 2017;33(7):830–835. doi: 10.1080/02656736.2017.1306120.
  • Oshima F, Yamakado K, Nakatsuka A, et al. Simultaneous microwave ablation using multiple antennas in explanted bovine livers: relationship between ablative zone and antenna. Radiat Med. 2008;26(7):408–414. doi: 10.1007/s11604-008-0251-x.
  • Yu NC, Raman SS, Kim YJ, et al. Microwave liver ablation: influence of hepatic vein size on heat-sink effect in a porcine model. J Vasc Interv Radiol. 2008;19(7):1087–1092. doi: 10.1016/j.jvir.2008.03.023.
  • Puza CJ, Wang Q, Kim CY. Evaluation of the heat sink effect after transarterial embolization when performed in combination with thermal ablation of the liver in a rabbit model. Cardiovasc Intervent Radiol. 2018;41(11):1773–1778. doi: 10.1007/s00270-018-2034-9.
  • de Baere T, Bessoud B, Dromain C, et al. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. Am J Roentgenol. 2002;178(1):53–59. doi: 10.2214/ajr.178.1.1780053.
  • Chinn SB, Lee FT, Kennedy GD, et al. Effect of vascular occlusion on radiofrequency ablation of the liver: results in a porcine model. Am J Roentgenol. 2001;176(3):789–795. doi: 10.2214/ajr.176.3.1760789.
  • Moussa M, Goldberg SN, Tasawwar B, et al. Adjuvant liposomal doxorubicin markedly affects radiofrequency ablation-induced effects on periablational microvasculature. J Vasc Interv Radiol. 2013;24(7):1021–1033. doi: 10.1016/j.jvir.2013.03.006.
  • Wu H, Exner AA, Krupka TM, et al. Vasomodulation of tumor blood flow: effect on perfusion and thermal ablation size. Ann Biomed Eng. 2009;37(3):552–564. doi: 10.1007/s10439-008-9605-x.
  • Dietrich CF, Averkiou MA, Correas JM, et al. An EFSUMB introduction into dynamic Contrast-Enhanced ultrasound (DCE-US) for quantification of tumour perfusion. Ultraschall Med. 2012;33(4):344–351. doi: 10.1055/s-0032-1313026.
  • Lassau N, Bonastre J, Kind M, et al. Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the french multicenter support for innovative and expensive techniques study. Invest Radiol. 2014;49(12):794–800. doi: 10.1097/RLI.0000000000000085.
  • Welp C, Siebers S, Ermert H, et al. Investigation of the influence of blood flow rate on large vessel cooling in hepatic radiofrequency ablation. Biomed Tech (Berl). 2006;51(5-6):337–346. doi: 10.1515/BMT.2006.067.
  • Yang D, Li R, Zhang XH, et al. Perfusion characteristics of hepatocellular carcinoma at contrast-enhanced ultrasound: influence of the cellular differentiation, the tumor size and the underlying hepatic condition. Sci Rep. 2018;8(1):4713. doi: 10.1038/s41598-018-23007-z.
  • Nicolau C, Catalá V, Vilana R, et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol. 2004;14(6):1092–1099. doi: 10.1007/s00330-004-2298-0.
  • von Herbay A, Vogt C, Westendorff J, et al. Correlation between SonoVue enhancement in CEUS, HCC differentiation and HCC diameter: analysis of 130 patients with hepatocellular carcinoma (HCC). Ultraschall Med. 2009;30(6):544–550. doi: 10.1055/s-0028-1109745.